Skip to main content

Effect of interleukin-1β gene polymorphisms on clinicopathological features and disease activity of systemic lupus erythematosus

Abstract

Background

Systemic lupus erythematosus (SLE) is responsible for severe disability and represents a major cause of chronic illness. Interleukin (IL)1β is a proinflammatory cytokine. We aimed to explore the possible associations of IL1β-511C/T (rs16944) and IL1β +3954C/T (rs1143634) gene polymorphisms with SLE, and to detect whether these polymorphisms are associated with disease activity of SLE. Moreover, we aimed to clarify the effect of these polymorphisms on clinical and biochemical parameters of SLE.

Patients and methods

Polymorphisms of IL1β-511 and IL1β +3954 genes were assessed in a case-control study comprising 110 patients with SLE and 90 controls. Disease activities were assessed by systemic lupus erythematosus disease activity index (SLEDAI). Serum IL-1β was estimated using an enzyme-linked immune sorbent assay. Genetic variants were genotyped using PCR-restriction fragment length polymorphism.

Results

Our results revealed higher values of IL1β in patients with SLE. In addition, there was a significant positive correlation between IL-1β serum level and SLEDAI score. The CT genotype distribution was significantly higher in patients with SLE than controls. Regarding IL1β +3954 gene polymorphisms, our results showed nonsignificant difference between control and SLE groups. In an attempt to estimate the diagnostic power of serum IL1β serum in differentiating patients with SLE from the control group, we found that the sensitivity was 94.5%, and the specificity was 99%.

In conclusion, the CT genotype distribution of IL1β-511 was significantly higher in patients with SLE than controls. However, there was a nonsignificant difference regarding IL1β +3954 gene mutation.

References

  1. Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res 2012; 64:159–168.

    Article  Google Scholar 

  2. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006; 15:308–318.

    Article  CAS  Google Scholar 

  3. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus [abstract]. Autoimmun Rev 2010; 9:A277–A287.

    Article  CAS  Google Scholar 

  4. Rasmussen AK, Bendtzen K, Feldt-Rasmussen U. Thyrocyte-interleukin-1 interactions. Exp Clin Endocrinol Diabetes 2000; 108:67–71.

    Article  CAS  Google Scholar 

  5. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095–2147.

    Article  CAS  Google Scholar 

  6. García-González MA, Aísa MA, Strunk M, Benito R, Piazuelo E, et al. Relevance of IL-1 and TNF gene polymorphisms on interleukin-1beta and tumor necrosis factor-alpha gastric mucosal production. Hum Immunol 2009; 70:935–945.

    Article  Google Scholar 

  7. Stegger JG, Schmidt EB, Tjønneland A, Kopp TI, Sørensen TI, et al. Single nucleotide polymorphisms in IL1B and the risk of acute coronary syndrome: a Danish case-cohort study. PLoS One 2012; 7:e36829.

    Article  CAS  Google Scholar 

  8. Tsai LJ, Hsiao SH, Tsai JJ, Lin CY, Tsai LM, Lan JL. Higher genetic susceptibility to inflammation in mild disease activity of systemic lupus erythematosus. Rheumatol Int 2009; 29:1001–1011.

    Article  CAS  Google Scholar 

  9. Parks CG, Cooper GS, Dooley MA. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population-based study in the southeastern United States. Ann Rheum Dis 2004; 63:91–94.

    Article  CAS  Google Scholar 

  10. Johnsen AK, Plenge RM, Butty V. A broad analysis of IL1 polymorphism and rheumatoid arthritis. Arthritis Rheum 2008; 58:1947–1957.

    Article  CAS  Google Scholar 

  11. Fagiolo E, Vigevani F, Pozzetto U. High cytokine serum levels in patients with autoimmune hemolytic anemia (AIHA). Immunol Invest 1994; 23:449–456.

    Article  CAS  Google Scholar 

  12. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29:288–291.

    Google Scholar 

  13. Meenakshi P, Ramya S, Shruthi T, Lavanya J, Mohammed HH, Mohammed SA, et al. Association of IL-1b +3954C/T and IL-10-1082 G/ A cytokine gene polymorphisms with susceptibility totuberculosis. Scand J Immunol 2013; 78:92–97.

    Article  CAS  Google Scholar 

  14. Bhat IA, Naykoo NA, Qasim I, Ganie FA, Yousuf Q, Bhat BA, et al. Association of interleukin 1 beta (IL-1β) polymorphism with mRNA expression and risk of non small cell lung cancer. Meta gene 2014; 31:123–133.

    Article  Google Scholar 

  15. Marinou I, Walters K, Dickson MC, Binks MH, Bax DE, et al. Evidence of epistasis between interleukin 1 and selenoprotein-S with susceptibility to rheumatoid arthritis. Ann Rheum Dis 2009; 68:1494–1497.

    Article  CAS  Google Scholar 

  16. O’Sullivan BJ, Thomas HE, Pai S, Santamaria P, Iwakura Y, et al. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol 2006; 176:7278–7287.

    Article  Google Scholar 

  17. Rus V, Atamas SP, Shustova V, et al. Expression of cytokine-and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol 2002; 102: 283–290.

    Article  CAS  Google Scholar 

  18. Muraki Y, Tsutsumi A, Takahashi R, et al. Polymorphisms of IL-1 beta gene in Japanese patients with Sjogren’s syndrome and systemic lupus erythematosus. J Rheumatol 2004; 31:720–725.

    CAS  PubMed  Google Scholar 

  19. Huang CM, Wu MC, Wu JY, Tsai FJ. Lack of association of interleukin-1beta gene polymorphisms in Chinese patients with systemic lupus erythematosus. Rheumatol Int 2002; 21:173–175.

    Article  CAS  Google Scholar 

  20. Camargo JF, Correa PA, Castiblanco J, Anay J-M. Interleukin-1 beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun 2004; 5:609–614.

    Article  CAS  Google Scholar 

  21. Afshari Jalil JT, Rezaieyazdi Z, Mazhani M. Association of IL-1 beta gene polymorphism with susceptibility to systemic lupus erythematosus. Int J Rheumat Dis 2008; 11. DOI: 10.1111/j.1756-185X.2008.00326.x

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nearmeen M. Rashad MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rashad, N.M., Soliman, M.H., El-Shal, A.S. et al. Effect of interleukin-1β gene polymorphisms on clinicopathological features and disease activity of systemic lupus erythematosus. Egypt J Intern Med 31, 235–242 (2019). https://doi.org/10.4103/ejim.ejim_92_18

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_92_18

Keywords